
Albert Mark Navarro
Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1645, 1621, 2899, 1817 |
| Total Applications | 2079 |
| Issued Applications | 1540 |
| Pending Applications | 155 |
| Abandoned Applications | 410 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16091267
[patent_doc_number] => 20200199620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => Viral Vector Constructs for Expression of Genetic Adjuvants Activating the CD40 and STING Pathways
[patent_app_type] => utility
[patent_app_number] => 16/464496
[patent_app_country] => US
[patent_app_date] => 2017-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12056
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464496
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464496 | Viral vector constructs for expression of genetic adjuvants activating the CD40 and STING pathways | Nov 27, 2017 | Issued |
Array
(
[id] => 14775127
[patent_doc_number] => 20190262461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => METHOD OF PRODUCING AN IMMUNOLIGAND/PAYLOAD CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 15/819116
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819116
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819116 | Method of producing an immunoligand/payload conjugate | Nov 20, 2017 | Issued |
Array
(
[id] => 16336768
[patent_doc_number] => 10787715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Methods for culture and identification of mycrobacterium avium subspecies in crohn's disease
[patent_app_type] => utility
[patent_app_number] => 15/819155
[patent_app_country] => US
[patent_app_date] => 2017-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 5266
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15819155
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/819155 | Methods for culture and identification of mycrobacterium avium subspecies in crohn's disease | Nov 20, 2017 | Issued |
Array
(
[id] => 12813241
[patent_doc_number] => 20180162917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES
[patent_app_type] => utility
[patent_app_number] => 15/814723
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15356
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15814723
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/814723 | Recombinant proteins and their therapeutic uses | Nov 15, 2017 | Issued |
Array
(
[id] => 13551791
[patent_doc_number] => 20180327443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => NANOPARTICLES, PROCESS FOR PREPARATION AND USE THEREOF AS CARRIER FOR AMPHIPATIC AND HYDROPHOBIC MOLECULES IN FIELDS OF MEDICINE INCLUDING CANCER TREATMENT AND FOOD RELATED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/815488
[patent_app_country] => US
[patent_app_date] => 2017-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15815488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/815488 | Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds | Nov 15, 2017 | Issued |
Array
(
[id] => 17976651
[patent_doc_number] => 11493508
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells
[patent_app_type] => utility
[patent_app_number] => 16/349183
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 27
[patent_no_of_words] => 24590
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 206
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16349183
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/349183 | Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells | Nov 12, 2017 | Issued |
Array
(
[id] => 15006273
[patent_doc_number] => 10449242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Compositions and methods for the treatment and prevention of Ebp pilus-related diseases
[patent_app_type] => utility
[patent_app_number] => 15/811250
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 56
[patent_no_of_words] => 23560
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15811250
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/811250 | Compositions and methods for the treatment and prevention of Ebp pilus-related diseases | Nov 12, 2017 | Issued |
Array
(
[id] => 15631993
[patent_doc_number] => 10588964
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Bacterial RNAs as vaccine adjuvants
[patent_app_type] => utility
[patent_app_number] => 15/809130
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 29
[patent_no_of_words] => 13741
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809130
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809130 | Bacterial RNAs as vaccine adjuvants | Nov 9, 2017 | Issued |
Array
(
[id] => 16428314
[patent_doc_number] => 10828375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Distribution of engineered-cysteine caps
[patent_app_type] => utility
[patent_app_number] => 16/347919
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7212
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347919 | Distribution of engineered-cysteine caps | Nov 5, 2017 | Issued |
Array
(
[id] => 15083473
[patent_doc_number] => 20190336547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => COMPOSITION FOR THE PREVENTIVE OR CURATIVE TREATMENT OF LIVER DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/345680
[patent_app_country] => US
[patent_app_date] => 2017-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16345680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/345680 | COMPOSITION FOR THE PREVENTIVE OR CURATIVE TREATMENT OF LIVER DISORDERS | Oct 29, 2017 | Abandoned |
Array
(
[id] => 17586573
[patent_doc_number] => 11324815
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Vaccine constructs and uses thereof against
[patent_app_type] => utility
[patent_app_number] => 16/337457
[patent_app_country] => US
[patent_app_date] => 2017-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 63
[patent_no_of_words] => 34004
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16337457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/337457 | Vaccine constructs and uses thereof against | Oct 19, 2017 | Issued |
Array
(
[id] => 14990941
[patent_doc_number] => 20190314428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => METHODS AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF THE SKIN MICROBIOME USING COMPLEX MIXTURES OF BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/343277
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343277 | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains | Oct 18, 2017 | Issued |
Array
(
[id] => 14990941
[patent_doc_number] => 20190314428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => METHODS AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF THE SKIN MICROBIOME USING COMPLEX MIXTURES OF BACTERIAL STRAINS
[patent_app_type] => utility
[patent_app_number] => 16/343277
[patent_app_country] => US
[patent_app_date] => 2017-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343277
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343277 | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains | Oct 18, 2017 | Issued |
Array
(
[id] => 14599511
[patent_doc_number] => 10352945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Optogenetic probes for measuring membrane potential
[patent_app_type] => utility
[patent_app_number] => 15/783886
[patent_app_country] => US
[patent_app_date] => 2017-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 43
[patent_no_of_words] => 41096
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15783886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/783886 | Optogenetic probes for measuring membrane potential | Oct 12, 2017 | Issued |
Array
(
[id] => 16876885
[patent_doc_number] => 11027005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
[patent_app_type] => utility
[patent_app_number] => 16/340778
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 4569
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340778
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340778 | Method for producing Hib conjugate vaccine using PRP with lowered molecular weight | Oct 10, 2017 | Issued |
Array
(
[id] => 16053189
[patent_doc_number] => 20200188449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => Compositions and Methods for Treating Chronic Fatigue Syndrome and Related Disorders
[patent_app_type] => utility
[patent_app_number] => 16/341164
[patent_app_country] => US
[patent_app_date] => 2017-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341164
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341164 | Compositions and Methods for Treating Chronic Fatigue Syndrome and Related Disorders | Oct 10, 2017 | Abandoned |
Array
(
[id] => 12150156
[patent_doc_number] => 20180021420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII'
[patent_app_type] => utility
[patent_app_number] => 15/722908
[patent_app_country] => US
[patent_app_date] => 2017-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19534
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15722908
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/722908 | METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII | Oct 1, 2017 | Abandoned |
Array
(
[id] => 14132707
[patent_doc_number] => 20190100743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => METHOD OF MAKING A VACCINE
[patent_app_type] => utility
[patent_app_number] => 15/720336
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15720336
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/720336 | Method of making a vaccine | Sep 28, 2017 | Issued |
Array
(
[id] => 14713235
[patent_doc_number] => 20190247681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => ANTISEPTIC-TOLERANT LACTIC ACID BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/338745
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338745 | Antiseptic-tolerant lactic acid bacteria | Sep 28, 2017 | Issued |
Array
(
[id] => 12259434
[patent_doc_number] => 20180078631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'SYNTHETIC IMMUNOGENS FOR PROPHYLAXIS OR TREATMENT OF TUBERCULOSIS'
[patent_app_type] => utility
[patent_app_number] => 15/715300
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 24474
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15715300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/715300 | Synthetic immunogens for prophylaxis or treatment of tuberculosis | Sep 25, 2017 | Issued |